Literature DB >> 25721565

New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal.

Guy Chouinard1, Virginie-Anne Chouinard.   

Abstract

Year:  2015        PMID： 25721565     DOI： 10.1159/000371865

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN： 0033-3190            Impact factor:   17.659


× No keyword cloud information.
  21 in total

1.  Lormetazepam in oral solution: a formulation at risk of high-dose use.

Authors:  Fiammetta Cosci; Antonio Egidio Nardi; Vladan Starcevic; Guy Chouinard; Richard Balon
Journal:  Intern Emerg Med       Date:  2019-07-03       Impact factor: 3.397

Review 2.  Antidepressant Withdrawal and Rebound Phenomena.

Authors:  Jonathan Henssler; Andreas Heinz; Lasse Brandt; Tom Bschor
Journal:  Dtsch Arztebl Int       Date:  2019-05-17       Impact factor: 5.594

3.  The Efficacy of a Group CBT Relapse Prevention Program for Remitted Anxiety Disorder Patients Who Discontinue Antidepressant Medication: A Randomized Controlled Trial.

Authors:  Willemijn D Scholten; Neeltje M Batelaan; Patricia van Oppen; Johannes H Smit; Adriaan W Hoogendoorn; Harold J G M van Megen; Daniëlle C Cath; Anton J L M van Balkom
Journal:  Psychother Psychosom       Date:  2018-06-01       Impact factor: 17.659

Review 4.  Subtherapeutic doses of SSRI antidepressants demonstrate considerable serotonin transporter occupancy: implications for tapering SSRIs.

Authors:  Bryan B Shapiro
Journal:  Psychopharmacology (Berl)       Date:  2018-08-10       Impact factor: 4.530

5.  The pursuit of euthymia.

Authors:  Giovanni A Fava; Jenny Guidi
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

6.  Antidepressant Use by Class: Association with Major Adverse Cardiac Events in Patients with Coronary Artery Disease.

Authors:  Sherry L Grace; Jose R Medina-Inojosa; Randal J Thomas; Heather Krause; Kristin S Vickers-Douglas; Brian A Palmer; Francisco Lopez-Jimenez
Journal:  Psychother Psychosom       Date:  2018-03-13       Impact factor: 17.659

7.  Initial Steps to inform selection of continuation cognitive therapy or fluoxetine for higher risk responders to cognitive therapy for recurrent major depressive disorder.

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Michael E Thase; Robin B Jarrett
Journal:  Psychiatry Res       Date:  2017-03-22       Impact factor: 3.222

Review 8.  Failure to Respond after Reinstatement of Antidepressant Medication: A Systematic Review.

Authors:  Renske C Bosman; Ruth C Waumans; Gabriel E Jacobs; Richard C Oude Voshaar; Anna D T Muntingh; Neeltje M Batelaan; Anton J L M van Balkom
Journal:  Psychother Psychosom       Date:  2018-07-24       Impact factor: 17.659

Review 9.  Well-being Therapy in Depressive Disorders.

Authors:  Giovanni Mansueto; Fiammetta Cosci
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient-level data meta-analysis.

Authors:  Ralitza Gueorguieva; Adam M Chekroud; John H Krystal
Journal:  Lancet Psychiatry       Date:  2017-02-09       Impact factor: 27.083
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.